Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00332774
Status:
COMPLETED
Last Update Posted:
2012-03-05
First Post:
2006-06-01
Brief Title:
Nevanac 3-Month Safety Study With QID Dosing
Sponsor:
Alcon Research
Organization:
Alcon Research
Study Overview
Official Title:
A 3-Month Clinical Safety Comparison of Nevanac 01 to Acular LS 04 and Vehicle Following Cataract Surgery
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the safety of Nevanac 01 compared to Acular LS 04 and Vehicle in patients treated before cataract surgery and for approximately 90 days following surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None